Results 81 to 90 of about 371,996 (314)

UBC First Nations Graduation 1998

open access: yes, 1998
Shirley Sterling and Kieren Muller, Francine Spahan, Eduardo Jovel, Karmen Smith, Lee Crowchild, Elizabeth Dance, Gloria Cole, Anita Carpenter, Michelle Hopkins, Tracy Healy, Marilyn Dumont, Gayle Bedard, Sherry Victor, Linda Wilson, Heather Commodore ...

core  

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

UBC 1997 First Nations Graduates

open access: yes, 1997
Back Row: Mary McNeill, Stefany Mathias, Lennard Joe, Marietta Einarson, Allyson Anderson, Nadine Caron, Bernice Touchie, Dr. Daniel Birch / Middle Row: Earla Calahaisn, Kika Mowry, Mar-y-paz Rivera, Francesa Vinson, Peter Nyce, JoAnne Moiese-Bob ...

core  

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

First Nations Graduates 2001-2002

open access: yes, 2002
Shannon Waters, Gilbert Anderson Jr., Jaya Supernant, Kisha Supernant, Jaimee Charlie, Shawn Hunt, Leah Fointain, Donna Koop, Lee Robin Caffrey, Don McIntyre, Graeme Joseph, Jennifer Mackie, Jan Hare, Ursula Schmitt, Wendy Lynn Gaspard, Odelia Dennis ...

core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Food Systems Leadership

open access: yesJournal of Agriculture, Food Systems, and Community Development, 2018
First paragraph: Food Leadership: Leadership and Adult Learning for Global Food Systems, edited by Catherine Etmanski (2017), consists of eight papers in three sections: Indigenous food systems, leadership in global food system transformation, and ...
Keith Williams
doaj   +1 more source

Reflections of a Mi’kmaq social worker on a quarter of a century work in First Nations child welfare

open access: yes, 2007
First Nations people would argue that the ‘Sixties Scoop’ of removing their children from their homes and culture never ended. First Nations children entering ‘care’ of child welfare agencies has increased significantly since the 1960s and 1970s. Storying
MacDonald, Nancy, MacDonald, Judy
core   +1 more source

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy